Tag: competition

Sheridan, WY , June 18, 2025 (GLOBE NEWSWIRE) --

Patent-protected Nura Wallet NOW LIVE on Google Play Store with $NURA token exploding onto DEX exchanges June 18th - The AI wallet that actually makes you money is here

Your crypto just became intelligent. The revolutionary Nura Wallet is NOW AVAILABLE on Google Play Store, featuring the world's first AI that automatically maximizes your DeFi profits 24/7. Tomorrow, June 18th, the $NURA token launches on DEX exchanges, completing the first crypto ecosystem where your wallet literally works to make you richer.

Download the future NOW: https://play.google.com/store/apps/details?id=com.nuralab

This isn't just another wallet launch. This is the commercial debut of patent-protected AI technology (US 63/819,482) that's about to bring a billion new users into DeFi.

The Autonomous Machine Is Live and Ready

The Nura Wallet does what every crypto holder has dreamed of: it automatically finds the best yields across hundreds of DeFi protocols and optimizes your returns around the clock. No more missing opportunities. No more complex strategies. Just pure, automated profit maximization - and it's available RIGHT NOW on your Android device.

"We just made every other crypto wallet obsolete," said the Nura Labs team. "Our AI doesn't just store your crypto - it actively works to multiply it. Users are seeing 23% higher yields and 67% lower fees. This is the iPhone moment for DeFi, and everyone can download it today."

$NURA Token: The Fuel Behind The Autonomous Machine

Tomorrow's $NURA token launch isn't just another token drop - it's the key that unlocks premium AI features that could transform your portfolio:

- Premium AI Optimization - Advanced algorithms that crush basic strategies

- Fee Elimination - Massive transaction cost reductions

- Exclusive Yields - Access to premium staking opportunities

- Governance Power - Vote on which protocols get integrated next

- Compounding Rewards - Stake $NURA for additional yield amplification

This token has REAL utility from day one through the live wallet application you can download right now.

The Numbers That Will Blow Your Mind

Users who already downloaded the app are going absolutely crazy over the results:

- 23% higher staking yields than manual management

- 67% lower transaction costs through AI optimization

- 89% less time required - literally set and forget

- 94% user satisfaction - people are obsessed

- 5,000+ beta users already maximizing profits with the live app

These aren't projections. This is real money being made by real users RIGHT NOW.

Why This Launch Is About To EXPLODE

- Available TODAY: Download immediately from Google Play Store

- Patent Protection: Legal moat around breakthrough technology

- First-Mover Advantage: No competition in AI wallet space

- Massive Market: $180B DeFi market with <10% penetration

- Real Utility: Token powers live, working application

- Mobile-First: Perfect for 100M+ smartphone crypto users

The Revolution Starts RIGHT NOW

TODAY: Download Nura Wallet and experience the future

TOMORROW: $NURA token trading begins on major DEX platforms

THIS WEEK: Watch your crypto start working harder than it ever has

The beta is over. The waiting is over. The DeFi complexity crisis is OVER.

Get The App That's Changing Everything

Download Nura Wallet NOW:

https://play.google.com/store/apps/details?id=com.nuralab

$NURA Trading Begins: June 18, 2025 on major DEX platforms

Website: https://nura.gg/

Token Launch Details

$NURA Trading Begins: June 18, 2025

Initial Pairs: $NURA/ETH, $NURA/USDC

Exchanges: Major DEX platforms

Utility: Live from day one through Nura Wallet

About Nura Labs

Nura Labs just solved crypto's biggest problem: making DeFi work for everyone. Our patent-protected AI technology transforms any smartphone into an institutional-grade profit machine. The complexity barrier is DEAD. The profit barrier is DEMOLISHED.

 DOWNLOAD NOW. YOUR CRYPTO IS WAITING TO GET SMARTER.

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

Aliso Viejo, CA , June 18, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., developer of the Life Backup Plan digital health platform, proudly announces its advancement to the second round of Pepperdine University’s Most Fundable Companies® 2025 competition. The company earned a “B” rating, reflecting “Great Potential” among a competitive national pool of startups evaluated for scalability, business fundamentals, and investor appeal.

DÜSSELDORF, Germany and ATLANTA, June 18, 2025 (GLOBE NEWSWIRE) -- Heramba Electric plc (OTC: PITEF) announced today the results of an extraordinary shareholder and board meeting held on June 3, 2025. More than 90.0%+ of shareholders voted on the following resolutions:

CAMBRIDGE, Mass., June 18, 2025 (GLOBE NEWSWIRE) --  Biogen Inc. (Nasdaq: BIIB) announced the initiation of dosing in the BRAVE study, a global Phase 3 clinical trial. The BRAVE study will evaluate the efficacy and safety of omaveloxolone in children with Friedreich ataxia (FA) between the ages of 2 to <16. Both non-ambulatory and ambulatory participants may qualify for the study. Participants will be randomized 2:1 to receive omaveloxolone or placebo once a day for 52 weeks before having the opportunity to move into the open-label extension (OLE). Currently, omaveloxolone is commercialized under the brand name SKYCLARYS^® in over 40 countries, including in the U.S. and the European Union, and is the only approved product for FA in adults and adolescents aged 16 years and older.

Explore the Phenylketonuria Therapeutics market with our comprehensive report, detailing current and future competition. Discover key trends, pipeline developments, and market dynamics shaping the PKU landscape through data-driven insights and expert analysis. Stay ahead in this evolving therapeutic domain.